The Information's TITV Future of Health Tech with Oura CEO, Brex CEO on Fintech’s Growth, AI for Scientific Discovery | Oct 14, 2025
16 snips
Oct 14, 2025 
Tom Hale, CEO of Oura, discusses the company’s recent $900M funding for AI-driven health tech innovations and its FDA strategy for medical devices. Pedro Franceschi, CEO of Brex, shares insights on their successful turnaround and ambitious plans in the fintech space, including their focus on automation and market expansion. Joseph Krause, CEO of Radical AI, reveals how AI-powered robotic labs are revolutionizing materials discovery, targeting high-entropy alloys for extreme environments. Expect a deep dive into the future of health tech and fintech!
AI Snips
Chapters
Transcript
Episode notes
AI As Core To Oura’s Strategy
- Oura sees AI as central to its future, funding talent and model development to scale health services.
- The company plans to combine continuous ring data with physiology models to create personalized health intelligence.
Three Layers Of AI At Oura
- Oura runs three AI surfaces: signal-processing models, personalized 'doctor-in-your-pocket' models, and LLMs for interpretation.
- They develop most physiology models internally while using open and closed LLMs for conversational insights.
Run Health AI On The Edge
- Prioritize privacy by placing as much AI processing as possible on-device at the edge.
- Use edge processing to reduce cloud costs and leverage latent device compute while keeping user data private.